Orphazyme board on CEO changes: She had an old-fashioned management style

Kim Stratton preferred leaving the role of CEO at Orphazyme over fulfilling the board of directors' requirements that she include the board and executive team in her decisions, says Vice Chair Bo Jesper Hansen. "Some would call her management style very American, but I think it's more that; it's old-fashioned," he says.
Kim Stratton, former CEO, Orphazyme
Kim Stratton, former CEO, Orphazyme

On Thursday, the biotech firm Orphazyme announced that the CEO Kim Stratton would no longer be working at the firm after serving for just one year and two months, but she was not fired.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading